Not really, I'm still expecting a lot of clinical trial updates end of this year and then a T/O for all of IMU's IP in 12 months time with HER-Vaxx completed Ph2, PD1-Vaxx will be 18 months into Ph2, Azer-Cel at the start of registrational clinical trial, Vaxinia will be 6 months into Ph2 and CF33 + CD19 will be end of Ph1.
From the Professor..., page-114
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $422.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.6¢ | $353.0K | 6.168M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 652434 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 476705 | 16 |
View Market Depth
| Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |